Nucala 100 mg Injection 1 ml belongs to the class of 'immunomodulators', primarily used to treat asthma. Asthma is a respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. Nucala 100 mg Injection 1 ml is used as an add-on maintenance treatment in severe asthma patients above six years of age and in patients with chronic rhinosinusitis with nasal polyps. It is also used in the treatment of hypereosinophilic syndrome and eosinophilic granulomatosis.
Nucala 100 mg Injection 1 ml consists of Mepolizumab as an active ingredient, which binds itself to interleukin-5 (IL-5) and stops it from attaching to its receptor on the surface of eosinophil white blood cells, specifically the alpha subunit of the receptor. It works by preventing the body's natural production of certain chemicals that increase asthma symptoms, like coughing, wheezing, chest pain, and breathing difficulties.
Nucala 100 mg Injection 1 ml may cause common side effects such as fever, back pain, itching, headache, sore throat, and breathing difficulty. These side effects resolve over time. Inform your doctor if any of these side effects bother you. Nucala 100 mg Injection 1 ml will be administered by a healthcare professional. Do not self-administer
Avoid taking Nucala 100 mg Injection 1 ml and inform your doctor if you are allergic to any component present in it. Before starting Nucala 100 mg Injection 1 ml, inform your doctor if you have any liver or kidney disease or active parasitic infections and are taking any inhaled corticosteroids. Pregnant and breastfeeding mothers should inform the physician before starting treatment with Nucala 100 mg Injection 1 ml. This medicine is contraindicated in cases of bronchospasm or status asthmaticus.